Pd0053 50119 — New York, New York

Pd0053 50119 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Pd0053 50119 has participated in 1 clinical trials.

Therapeutic areas: Early-stage Parkinson's Disease.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pd0053 50119?

Pd0053 50119 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pd0053 50119 conducted?

Pd0053 50119 has 1 clinical trials on record. Their work covers Early-stage Parkinson's Disease.

Is Pd0053 50119 accredited by Crixeo Health?

Pd0053 50119 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pd0053 50119?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.